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Precursor cells of the embryonic cortex sequentially
generate neurons and then glial cells, but the mecha-
nisms regulating this neurogenic-to-gliogenic transi-
tion are unclear. Using cortical precursor cultures,
which temporally mimic this in vivo differentiation pat-
tern, we demonstrate that cortical neurons synthesize
and secrete the neurotrophic cytokine cardiotrophin-
1, which activates the gp130-JAK-STAT pathway and
is essential for the timed genesis of astrocytes in vitro.
Our data indicate that a similar phenomenon also oc-
curs in vivo. In utero electroporation of neurotrophic
cytokines in the environment of embryonic cortical
precursors causes premature gliogenesis, while acute
perturbation of gp130 in cortical precursors delays the
normal timed appearance of astrocytes. Moreover,
the neonatal cardiotrophin-12/2 cortex contains fewer
astrocytes. Together, these results describe a neural
feedback mechanism; newly born neurons produce
cardiotrophin-1, which instructs multipotent cortical
precursors to generate astrocytes, thereby ensuring
that gliogenesis does not occur until neurogenesis
is largely complete.
Introduction
Development of the cerebral cortex is achieved through
a common pool of precursor cells that sequentially gen-
erate neurons and glial cells. Remarkably, this precisely
timed process can be recapitulated in vitro with isolated
embryonic cortical stem cells (Qian et al., 2000), sug-
gesting that cortical precursors are biased initially to
generate neurons and that an undefined mechanism in-
structs them to generate astrocytes at later time points.
*Correspondence: fredam@sickkids.caOne potential explanation for this timing mechanism is
a cell-intrinsic one where, over time, precursor cells
themselves change so they are less biased to make
neurons and more likely to make glial cells. Such
a change could occur, for example, as a consequence
of dilution of a neurogenic factor(s) such as a transcrip-
tion factor (Nieto et al., 2001; Sun et al., 2001; Me´nard
et al., 2002; He et al., 2005), by expression of a receptor
such as EGFR (Burrows et al., 1997; Sun et al., 2005), or
by demethylation of astrocyte-specific gene promoters
(Takizawa et al., 2001). Another, not mutually exclusive,
explanation is that cortical precursor cells are prema-
turely competent to generate astrocytes, but they re-
quire an extrinsic gliogenic signal that is not present in
their environment until later in embryogenesis. Indeed,
several exogenous growth factors have been shown to
be potent gliogenic factors (reviewed in Sauvageot
and Stiles, 2002). In particular, the interleukin-6 (IL-6)
family of neurotrophic cytokines, which includes leuke-
mia inhibitory factor (LIF), ciliary neurotrophic factor
(CNTF), and cardiotrophin-1 (CT-1), induces premature
astrocyte formation in cultured cortical precursors via
a gp130-JAK-STAT pathway (Bonni et al., 1997; Rajan
and McKay, 1998; Ochiai et al., 2001), and targeted ab-
lation of the genes encoding either gp130 or its core-
ceptor LIFR perturbs astrocyte formation in vivo (Ware
et al., 1995; Koblar et al., 1998; Nakashima et al., 1999a).
While these latter studies indicate that cytokine sig-
naling is important, the finding that the appropriate tim-
ing of astrogenesis is mimicked in isolated clones of
precursor cells seems to argue that a cell-intrinsic
mechanism regulates the onset of gliogenesis (Qian
et al., 2000). However, since such clones contain both
precursors and newly born neurons, a second hypothe-
sis is that newly born neurons secrete gliogenic factors
that feed back to instruct multipotent precursors to gen-
erate astrocytes. Here, we describe data that support
this hypothesis. Specifically, we demonstrate that newly
born neurons secrete the gliogenic cytokine CT-1,
which then instructs cortical precursors to generate as-
trocytes at the appropriate time and in the appropriate
number. These findings support a model where cortical
precursors are competent to generate astrocytes early
during cortical development, but only later in embryo-
genesis, when levels of neuron-secreted CT-1 are suffi-
ciently high, do these precursors receive the necessary
gliogenic signal to initiate astrocyte formation, thereby
ensuring that gliogenesis does not commence until neu-
rogenesis is largely complete.
Results
Mixed Cortical Neuron and Precursor Cultures
Induce Premature Astrocyte Formation
from Early Cortical Precursors
To study mechanisms responsible for the sequential
generation of neurons and glia, we examined primary
murine (embryonic day 13) E13 cortical precursor cells
(Toma et al., 2000; Me´nard et al., 2002; Barnabe´-Heider
and Miller, 2003), a system that we have previously
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254Figure 1. Conditioned Medium from Mixed
Neuron and Cortical Precursor Cultures In-
structs Multipotent Cortical Precursors to
Generate Astrocytes Prematurely
(A) GFAP immunofluorescence (red) in pre-
cursors cultured for 2, 4, and 6 DIV in 50
ng/ml CNTF, LIF, or CT-1 or 4 DIV CM. Scale
bar, 100 mm.
(B) Western blots of precursors after 2–9 DIV
for nestin, cdk2, NFM, and GFAP.
(C and D) Western blots of precursors cul-
tured for 6 days in CNTF or in two sets of 4
DIV or 6 DIV CM (expt. 1 and expt. 2) (C) or
in a third batch of 4 DIV CM that was or
was not heat denatured (CM-4 and CM-4-
heat) (D). Blots were probed for NFM, bIII-
tubulin, and GFAP and reprobed for total
ERK levels as a loading control.
(E–H) Clonal analysis demonstrates that con-
ditioned medium recruits multipotent corti-
cal precursors to generate astrocytes. (E
and F) E13 EYFP-tagged precursors were
cultured at clonal density with age-matched
CD1 precursors for 4 (E) or 5 (F) days in
CM and immunostained for EYFP (GFP,
green) and GFAP or MAP2 (both red). Photo-
micrographs show individual clones, and ar-
rows show double-labeled cells. Scale bar,
50 and 100 mm in (E) and (F), respectively.
(G and H) Number of clones containing cells
expressing GFAP (G), CD44 (H), or S100b (H)
in cultures grown in CNTF, CT-1, or CM ver-
sus control medium. CM1-4 refers to four in-
dependent batches of CM. In (A), (E), and (F),
cells were counterstained with Hoechst
33258 (blue) to show all cells in the field.characterized. Upon plating, these cortical precursors
were virtually all dividing, nestin-positive cells that se-
quentially generated neurons and then glia, as visualized
by immunocytochemistry and Western blots for neurofi-
lament-M (NFM; Figure 1B), glial fibrillary acidic protein
(GFAP; Figures 1A and 1B), galactocerebrosidase
(GalC), and CNPase (Figure S1A in the Supplemental
Data available with this article online). Neurons were first
observed after 1 day in vitro (DIV) (Figure 1B; data not
shown), while astrocytes and oligodendrocytes were
first seen at 5–6 DIV (Figures 1A and 1B; Figure S1A).
The increase in differentiated cells was accompaniedby a depletion of precursors, as shown by a reduction
in expression of nestin and the proliferating cell marker
cyclin-dependent kinase 2 (cdk2; Figure 1B).
One explanation for why gliogenesis follows neuro-
genesis in these cultures is that newly born neurons
produce a gliogenic factor. To test this possibility, we
exposed newly plated cortical precursors to medium
conditioned by 4-day-old cortical precursor cultures (4
DIV conditioned medium [CM]), which contain only neu-
rons and precursors (Figures 1A and 1B). As a positive
control, we used the known gliogenic cytokines CNTF,
LIF, and CT-1 (Bonni et al., 1997; Rajan and McKay,
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2551998; Ochiai et al., 2001). Immunocytochemistry for
GFAP revealed that at 4 DIV no astrocytes were present
in controls, but that cultures treated with CM or any of
the three cytokines contained astrocytes, the numbers
of which increased dramatically by 6 DIV (Figure 1A).
We extended these results by examining CD44 and
S100b, which we confirmed are expressed in astrocyte
precursors/early astrocytes and glial precursors/early
astrocytes, respectively, in these cultures (Figures S1B
and S1C; Burrows et al., 1997; Liu et al., 2004). As pre-
dicted, CD44- and S100b-positive cells were detected
earlier than those expressing GFAP (Figures S2A and
S2B), and at 4 DIV, CM increased their numbers by ap-
proximately 2-fold (Figures S2A and S2B; Figures 4J
and 4K). Western blots at 6 DIV confirmed these findings
and showed that levels of GFAP, but not NFM or bIII-tu-
bulin, were increased by CM (Figures 1C and 1D). Since
the gliogenic effect of the CM was inhibited by heat de-
naturation (Figure 1D), we conclude that it is likely due to
a secreted protein.
To ask whether this premature gliogenesis reflected
an increase in the number of cortical precursors that
generated astrocytes, we performed clonal analysis.
Since survival of cortical precursors is density depen-
dent (Barnabe´-Heider and Miller, 2003), we seeded
E13 EYFP-tagged transgenic cortical precursors at
clonal density on untagged E13 precursors. These cul-
tures were grown 4 or 5 days with or without 4 DIV CM
or CNTF; over this time period, single EYFP-positive
cells proliferated to generate clones (Figures 1E and
1F). Immunocytochemistry revealed that, in control
cocultures at 4 DIV, most clones contained cells ex-
pressing MAP2 and nestin, but no clones contained
GFAP-positive astrocytes (data not shown; Figure 1G).
By 5 DIV, a very small number of clones contained at
least one GFAP-positive cell (Figure 1G). In contrast,
when cells were cultured in 4 DIV CM, some clones con-
tained GFAP-positive cells at day 4 (Figures 1E and 1G),
while many more did on day 5 (Figures 1F and 1G). To
ask whether CM enhances genesis of astrocytes versus
enhancing differentiation of previously determined
astrocyte precursors, we also examined CD44 and
S100b (Figure 1H). At 4 DIV, 2 to 3 times as many clones
contained CD44- or S100b-positive cells when exposed
to CM (Figure 1H), an effect quantitatively similar to that
seen in cultures exposed to CNTF or CT-1 (Figures 1G
and 1H). In contrast, neither CM nor CNTF affected the
number of clones containing MAP2-positive neurons
or nestin-positive precursors (Figure 1F; data not
shown). Thus, a factor(s) secreted by the mixed precur-
sor/neuron cultures directs cortical precursors to gen-
erate astrocytes.
Purified Embryonic Cortical Neurons Secrete
Factors that Are Sufficient to Direct Early Cortical
Precursors to Generate Astrocytes
To identify the source of the gliogenic factors contained
in CM, we isolated purified embryonic cortical neurons,
using the K6 line of Ta1:nlacZ transgenic mice, which
expresses nuclear b-galactosidase from the neuron-
specific Ta1 a-tubulin promoter (Gloster et al., 1999).
E15-17 transgenic cortical cells were labeled with the
vital dye fluorescein di-b-D-galactopyranoside (FDG),
sorted by FACS, and cultured for 5 days.Immunocytochemistry demonstrated that 99.5% of the
cells expressed bIII-tubulin, the vast majority of which
also expressed MAP2 (Figure 2A), while no cells ex-
pressed glial markers (data not shown). CM was col-
lected from these purified neurons and applied to
newly isolated cortical precursors for 5 days. Immuno-
cytochemistry revealed that the control cultures con-
tained many MAP2-positive neurons with only the rare
GFAP-positive astrocyte, while the cultures grown in
neuron-derived CM contained both neurons and astro-
cytes (Figure 2B). Quantitation revealed that pure neu-
ron CM was similar to exogenous CNTF in its ability to
promote premature astrocyte formation (Figure 2C).
Developing Cortical Neurons Express Neurotrophic
Cytokines that Activate Downstream Cytokine
Signaling Pathways in Cortical Precursors
CNTF, CT-1, and LIF promote astrocyte differentiation
from cortical precursors via activation of the JAK-
STAT pathway (Bonni et al., 1997; Rajan and McKay,
1998; Nakashima et al., 1999b; Ochiai et al., 2001). To
determine whether the cortical neuron gliogenic fac-
tor(s) was a cytokine, we performed semiquantitative
RT-PCR. This analysis revealed that the mRNAs for
CNTF, LIF, and CT-1 were not expressed in freshly iso-
lated precursors but were detectable in mixed precur-
sor/neuron cultures at 6 DIV, with the highest levels in
cortical neurons isolated at E15 and cultured for 5 DIV
(Figure 2D). We also confirmed using RT-PCR and
Western blots that the gp130 receptor (required for ac-
tions of all the cytokines) and LIFR (required for actions
of LIF, CNTF, and CT-1) were expressed in cortical pre-
cursors from 0 to 8 DIV (Figure 2E; data not shown).
To confirm that cortical neurons produce cytokines,
we asked whether CM induced the JAK-STAT pathway.
Initially, we characterized the basal level of JAK-STAT
activation in cortical precursor cultures. Western blots
and immunocytochemistry revealed that JAK1, JAK2,
and STAT3 were all expressed from 1 to 6 DIV (Figure
2G), that STAT3 was enriched in precursors relative
to newly born neurons (Figure 2F), and that the phos-
phorylated, activated forms of JAKs 1 and 2 increased
at 4–6 DIV (Figure 2G) coincident with the predicted on-
set of endogenous gliogenic signaling. To ask whether
CM activated this same pathway, 4 DIV precursors
were washed, exposed to CM for 15 min, and analyzed
by Western blots. Results demonstrated that CM from
either purified neurons or 4 DIV precursors induced ac-
tivation of JAK2 and STAT3 (Figure 2H), as did CNTF.
CM and CNTF also acutely activated a second cytokine
signaling pathway, the MEK-ERK pathway, as assayed
with a phospho-ERK antibody (Figure 2H). Thus, newly
born cortical neurons secrete cytokines that activate
appropriate signaling pathways in multipotent cortical
precursors.
Cytokine Signaling through the JAK-STAT Pathway,
but Not through MEK, Is Necessary for Cortical
Neurons to Induce Premature Gliogenesis
Cytokines are thought to mediate gliogenesis from cor-
tical precursors by activation of the JAK-STAT but not
the MEK-ERK pathway, which is instead thought to pro-
mote neurogenesis in cortical precursors (Me´nard et al.,
2002; Barnabe´-Heider and Miller, 2003). To assess the
Neuron
256Figure 2. Embryonic Cortical Neurons Se-
crete Cytokines that Direct Multipotent Corti-
cal Precursors to Generate Astrocytes
(A) Immunostaining for bIII-tubulin (green) or
MAP2 (red) in E15 K6 cortical neurons puri-
fied by FACS and cultured 5 days. Scale
bar, 100 mm.
(B) Immunostaining for GFAP (red) and
MAP2 (green) in precursors cultured 5 days
without (top panels) or with (bottom panels)
neuron-derived CM. Scale bar, 100 mm.
(C) Percentage of GFAP-positive cells in ex-
periments performed as in (B) using two in-
dependent preparations of neuron-derived
CM (K6-CM1-2) or CNTF. ***p < 0.001 rela-
tive to control medium (ANOVA). Error bars
indicate SEM.
(D–H) Developing cortical neurons express
cytokines, and neuron-conditioned medium
activates cytokine signaling in cortical pre-
cursor cells. (D) RT-PCRs for CNTF, LIF,
and CT-1 mRNAs in freshly dissociated pre-
cursors (0), after culturing 3 or 6 DIV, or from
developing cortical neurons (CN). GAPDH
was used as a loading and genomic DNA
contamination control. (E) RT-PCRs (left)
and Western blots (right) for gp130 and LIFR
in precursors from 0 to 8 DIV. (F) Immunos-
taining for STAT3 (red) and nestin (green;
top panels) or MAP2 (green; bottom panels)
in 4 DIV precursors. Arrows denote the same
cells. Scale bar, 50 mm. (G) Western blots of
precursors at 2 to 6 DIV for STAT3, JAK1,
and JAK2 and their phosphorylated, acti-
vated forms (pSTAT3, pJAK1, and pJAK2).
(H) Western blots for phosphorylated STAT3,
JAK2, or ERKs (pSTAT3, pJAK2, pERKs) in 4
DIV precursors stimulated 15 min with CM
from 4 DIV precursors (CM-4DIV) or cortical
neurons (CM-CN), or with CNTF. Blots were
probed for total STAT3, JAK2, or ERKs as
loading controls. In (A), (B), and (F), cells
were counterstained with Hoechst 33258
(blue).role of these two pathways in CM-mediated gliogenesis,
we used AG490 and PD98059, which inhibit JAK and
MEK, respectively. To ascertain the specificity and effi-
cacy of these inhibitors, we cultured precursors for 3
days, at which point the peak of neurogenesis is over,
and then added CNTF or CM with or without 50 mM
PD98059 or 5 mM AG490 for 2 additional days. As pre-
dicted, PD98059 inhibited long-term ERK phosphoryla-
tion with no effect on the JAK-STAT pathway (Figure 3C;
data not shown), while AG490 had the converse effect
(Figure 3D). We then asked whether either of these
two inhibitors affected gliogenesis. Immunocytochem-
istry and Western blots revealed that AG490 but not
PD98059 decreased the gliogenic effect of CNTF and
completely abolished CM-induced astrocyte formation
(Figures 3A and 3C–3E). Neither inhibitor affected the
numbers of neurons (Figures 3C–3E), likely because
neurogenesis is largely complete by the time the inhib-
itors are added. Total cell numbers were also similar in
all conditions (CM-treated cultures had 10286 135 cells
per field with DMSO, 975 6 88 with AG490, and 1017 6
117 with PD98059), indicating that these inhibitors did
not affect survival or proliferation. Moreover, whenAG490 was applied at 7 DIV, after astrocytes were
already born, it had little or no effect on astrocyte
number (Figure 3B), arguing that it specifically affected
gliogenesis.
To confirm that the JAK-STAT pathway was essential
for CM-induced gliogenesis, we inhibited it genetically,
using siRNA for STAT3. To demonstrate the efficacy of
the STAT3 siRNA vector, we cotransfected it with an
EGFP expression plasmid into NIH-3T3 cells. Although
transfection efficiency was only 30%–50%, Western
blots demonstrated that STAT3 levels were decreased
at time points from 2 to 6 days posttransfection (Figure
4A; data not shown). We then asked whether STAT3
siRNA knockdown would inhibit gliogenesis; precursors
were cotransfected immediately after plating, cultured
in 4 DIV CM or CNTF, and analyzed after 5 days. The
efficacy of the siRNA was demonstrated by immunos-
taining cells for GFP and STAT3 (Figure 4B); 85% of
GFP-positive control cells versus 29% of STAT3
siRNA-transfected cells were immunoreactive for
STAT3. Immunostaining of these cultures for GFP and
GFAP or MAP2 revealed that STAT3 siRNA reproducibly
decreased by 2- to 3-fold the number of astrocytes
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257Figure 3. Inhibition of the JAK-STAT, but Not
the MEK Pathway, Prevents Conditioned
Medium-Induced Astrocyte Formation
(A) GFAP immunostaining (red) in precursors
cultured 3 days and treated for 2 additional
days with 4 DIV CM or CNTF with or without
5 mM AG490, 50 mM PD98059 (PD), or DMSO.
(B) GFAP immunostaining (red) in precursors
cultured 7 days and treated with AG490, as in
(A). In (A) and (B), cells were counterstained
with Hoechst 33258 (blue). Scale bars,
100 mm.
(C and D) Western blots of precursors treated
as in (A) with 50 mM PD98059 (C) or 5 mM
AG490 (D). Blots were probed with antibodies
to total or phosphorylated ERKs, STAT3, and
JAK2, or to GFAP and bIII-tubulin.
(E) Percentage of GFAP- or MAP2-positive
cells in one representative experiment of
three experiments that gave similar results
to that shown in (A). ***p < 0.001, **p < 0.01
relative to DMSO controls (ANOVA). Error
bars indicate SEM.generated in either CM or CNTF (Figures 4C and 4D). In-
terestingly, STAT3 knockdown also increased the num-
ber of neurons by approximately 2-fold (Figures 4C and
4D), indicating that the JAK-STAT pathway both enhan-
ces gliogenesis and inhibits neurogenesis.
These findings indicate that newly born neurons se-
crete factors that promote gliogenesis via the JAK-
STAT pathway. To determine whether these factors
are cytokines, we decreased levels of the cytokine re-
ceptor gp130 on cortical precursors using a mixed
pool of siRNA oligonucleotides. Western blots showed
that, when transfected into NIH-3T3 cells, these oligo-
nucleotides reduced gp130 levels relative to cells trans-
fected with a scrambled oligonucleotide (Figure 4E), in
spite of a transfection efficiency of only 30%–50%. We
then cotransfected cortical precursors with GFP and
gp130 siRNA at 1 day after plating and maintained
them for 4 additional days in 4 DIV CM or CNTF. This
protocol effectively reduced gp130 levels (Figure 4F);
82% of control cells versus 26% of gp130 siRNA-trans-
fected cells were immunoreactive for gp130. Immunos-
taining of these cultures for GFAP, S100b, and CD44
revealed that, relative to the scrambled oligonucleotide,gp130 knockdown dramatically reduced the number of
cells expressing these astrocyte precursor/astrocyte
markers in response to CM (Figures 4G–4K). The endog-
enous gliogenesis that occurs in control cultures was
also highly reduced (Figures 4J–4K). Interestingly,
gp130 knockdown increased the number of MAP2-pos-
itive neurons by approximately 2-fold (Figure 4G). Thus,
the gliogenic factor(s) in CM is a cytokine(s), and a re-
duction in gp130 signaling in cortical precursors inhibits
gliogenesis and promotes neurogenesis.
Cortical Precursor Cells in the Early Embryonic
Ventricular/Subventricular Zone Are Competent
to Generate Astrocytes in Response to Premature
Neurotrophic Cytokine Expression
Our findings suggest that cortical precursors are com-
petent to make astrocytes earlier in development but
that they do not do so because of low cytokine levels
in their environment. To test this idea, we expressed
the cytokine CNTF in the embryonic telencephalic VZ/
SVZ by performing in utero electroporation with a plas-
mid encoding a myc-tagged, secreted form of CNTF
(Jiang et al., 2003). As predicted, transfection of this
Neuron
258Figure 4. A Knockdown of Cytokine Signal-
ing Using siRNA for STAT3 or gp130 Inhibits
Conditioned Medium-Directed Astrogenesis
(A) Western blot for STAT3 in NIH 3T3 cells
transfected for 2 or 4 days with empty con-
trol vector (pSilencer) or STAT3 siRNA. The
blot was reprobed for ERK.
(B) Immunostaining for GFP (green) and
STAT3 (red) in precursors cotransfected 5
days earlier with GFP and either STAT3 siR-
NA (bottom panels) or empty pSilencer vec-
tor (top panels). Arrows and arrowheads
represent transfected cells.
(C) Immunostaining for GFP (green) and
GFAP (red; top panels) or MAP2 (red; bottom
panels) in precursors cotransfected as in (B)
and treated with 4 DIV CM. Arrows and ar-
rowheads denote transfected cells that do
or do not express the relevant marker pro-
tein, respectively.
(D) Quantitation of experiments similar to
those shown in (C), with CNTF treatment as
a positive control. For each condition, at
least 300 cells were counted in each of three
independent experiments (Expt. 1, Expt. 2,
and Expt. 3). ***p < 0.001, **p < 0.01, *p <
0.05 relative to vector-transfected cells (Stu-
dent’s t test). Error bars indicate SEM.
(E) Western blots of NIH 3T3 cells trans-
fected with gp130 or scrambled (scr) siRNA
oligonucleotides for 4 or 6 days. Untrans-
fected cells (cont) were run as a control.
The blot was reprobed for total ERKs.
(F) Immunostaining for GFP (green) and
gp130 (red) in precursors cotransfected 5
days earlier with the GFP plasmid and either
gp130 siRNA oligonucleotides (top panels)
or the scrambled oligonucleotide (control,
bottom panels). Arrowheads represent trans-
fected cells.
(G) Quantitation of cotransfected precursors
treated with 4 DIV CM or CNTF for 5 days
and immunostained for GFP and GFAP or
GFP and MAP2. For each condition, at least
300 cells were counted in each of three inde-
pendent experiments (Expt. 1, Expt. 2, and
Expt. 3). ***p < 0.001, **p < 0.01, *p < 0.05 relative to the scrambled oligonucleotide-transfected cells (Student’s t test). Error bars indicate SEM.
(H and I) Immunostaining for GFP (green) and CD44 (H) or S100b (I) (both red) in precursors treated as in (G). Arrowheads denote the same cells.
(J and K) Quantitation of experiments similar to those shown in (H) and (I). For each condition, at least 300 cells were counted in each of two in-
dependent experiments (Expt. 1 and Expt. 2). ***p < 0.001, **p < 0.01, *p < 0.05 relative to the scrambled oligonucleotide-transfected cells, or for
the control groups joined by black bars, between control and CM-treated cells (Student’s t test). Error bars indicate SEM. In (B), (C), (F), (H), and (I),
cells were counterstained with Hoechst 33258 (blue); scale bars, 100 mm.plasmid into COS cells led to secretion of CNTF into the
medium (Figure S3C). Moreover, when cortical precur-
sors were transfected with this plasmid, at 5 DIV more
than 30% of the cells expressed GFAP, and the JAK-
STAT pathway was robustly activated (Figures S3A–
S3C). Importantly, many nontransfected cells were
GFAP positive (Figure S3A), as would be predicted if
CNTF was secreted by the transfected cells.
We then performed in utero electroporation; plasmids
encoding a nuclear-targeted GFP and CNTF or empty
vector were coelectroporated following injection into
the E15 lateral ventricles, embryos were reimplanted,
and cortices were analyzed 1–3 days later. One day fol-
lowing electroporation, only cells in the VZ/SVZ of the
telencephalon were transfected (data not shown), as
previously reported (Ohtsuka et al., 1999). Three days
following electroporation, at E18, many cells were still
in the VZ/SVZ, but many had also migrated into thecortical plate (Figure 5A). Immunocytochemistry dem-
onstrated that virtually no GFAP-positive cells were de-
tected in the control-transfected E18 cortex (Figure 5A,
left panels) but that many astrocytes were present in
the CNTF-transfected cortical VZ/SVZ (Figure 5A, right
panels). Confocal microscopy revealed that approxi-
mately 20% of GFP-CNTF-positive cells in the SVZ
adopted an astrocytic fate (Figures 5B and 5C) and
that many nontransfected cells also expressed GFAP
(Figure 5B), as was seen in the culture experiments
(Figure S3A).
To ask how early cortical precursors were competent
to generate astrocytes in vivo, we performed the same
electroporation experiment at the earliest feasible time
point, E13.5. Immunocytochemical analysis of these
brains 2.5 days later, at E16, revealed abundant
GFAP-positive cells within the VZ/SVZ of CNTF-trans-
fected but not control-transfected animals (Figure 5F).
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259Figure 5. Embryonic Cortical Precursors Are
Competent to Respond to CNTF with Prema-
ture Gliogenesis In Vivo
(A–C) In utero electroporations of precursor
cells in the E15 telencephalic VZ/SVZ with
plasmids encoding GFP and either CNTF or
empty vector. Three days after electropora-
tion, coronal telencephalic sections were im-
munostained for GFP and GFAP. (A) E18
cortical sections from embryos transfected
with the empty vector (left panels) or with
CNTF plasmid (right panels) and immunos-
tained for GFAP (red, top) and GFP (green,
middle; bottom shows merged images). V,
ventricle; SVZ, subventricular zone; CP, cor-
tical plate; M, meninges. Scale bar, 200 mm.
(B) Confocal microscopic analysis of GFP
(green) and GFAP (red) expression in the
SVZ of sections similar to those in (A). Scale
bar, 100 mm. Arrows denote transfected
GFAP-positive cells, and arrowheads denote
nontransfected GFAP-positive cells. (C)
Quantitation of sections similar to those in
(B). Transfected cells within the SVZ of three
littermate pairs, four sections per embryo,
were counted. ***p < 0.001 relative to vec-
tor-transfected sections (Student’s t test).
Error bars indicate SEM.
(D and E) Immunostaining for GFAP (red)
and/or S100b (green) in E11.5 precursors
cultured for 5 DIV in CM (D) or 7 DIV in con-
trol medium (E). Cells were counterstained
with Hoechst 33258. Scale bar, 50 mm.
(F) E16 cortical sections that were electropo-
rated at E13.5 with either an empty vector or
a CNTF plasmid and immunostained for
GFAP (red). Arrows indicate regions of GFAP
immunoreactivity. Scale bar, 100 mm.Immunohistochemistry for S100b revealed a similar en-
hancement in the CNTF-transfected VZ/SVZ (data not
shown), arguing that CNTF promoted the premature
genesis of astrocytes, and not just their differentiation.
We also asked how early cortical precursors were
competent to respond to the cytokine(s) in CM; precur-
sors were cultured from the E11.5 cortex and exposed
to CM or CNTF. Immunocytochemical analysis revealed
that at 5 DIV (the earliest time point examined), many
S100b- and GFAP-positive astrocytes were present un-
der both of these conditions (Figure 5D), while none
were present in control cultures until 7 DIV (Figure 5E).
Thus, early cortical precursors are competent to re-
spond to cytokines both in culture and in vivo, arguing
that E13–E15 cortical precursor cells do not normally
produce astrocytes because of the limited availability
of gliogenic factors in their environment.
The Appropriate Onset of Gliogenesis
In Vivo Requires Cytokine Signaling
in Cortical Precursor Cells
While these findings argue that cortical precursors
are competent to respond to cytokines during embryo-
genesis, they do not demonstrate that cytokines regu-
late the appropriate onset of gliogenesis. To addressthis issue, we acutely perturbed cytokine signaling in
cortical precursors using gp130 siRNA. As previously
reported (Calegari et al., 2002), plasmids and siRNA oli-
gonucleotides can be efficiently coelectroporated into
the developing cortex and remain stably expressed
(data not shown). We therefore coelectroporated
a GFP plasmid with either scrambled or gp130 siRNA
oligonucleotides into the E14/15 telencephalon and an-
alyzed the cortices at postnatal day 3 (P3) or P4. Immu-
nocytochemistry for GFP and GFAP or NeuN revealed
that, in control animals, almost all of the GFAP-positive
cells were localized to the SVZ (Figure 6A), while the
vast majority of NeuN-positive neurons were in the cor-
tical plate (Figure 6D). Confocal analysis demonstrated
that, at P3, GFAP was expressed in 5%–10% of the
GFP-positive control-transfected cells, but in virtually
none of the gp130 siRNA-transfected cells (Figures 6B
and 6C). By P4, 20%–30% of the control, GFP-positive
cells expressed GFAP, while only approximately 5% of
the gp130 siRNA-transfected cells were GFAP positive
(Figures 6B and 6C). In contrast, gp130 siRNA knock-
down led to a small but significant increase in the num-
ber of transfected neurons in the cortical plate (Figures
6D and 6E), consistent with the culture data. Thus, the
appropriate onset of astrocyte formation requires the
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cursors Is Essential for the Appropriate On-
set of Astrocyte Formation In Vivo
gp130 siRNA or scrambled oligonucleotides
were coelectroporated with a control GFP
plasmid into E14/15 embryos, and neonatal
cortical sections were then immunostained
for GFP and GFAP (A–C) or GFP and NeuN
(D and E). (A) Immunostaining for GFAP
(red, left; also shown is the Hoechst 33258
counterstain in blue), GFP (green, middle;
right panels are the merged images) on P4
cortical sections from animals transfected
with either scrambled (top panels) or gp130
siRNAs (bottom panels). V, ventricle; SVZ,
subventricular zone; CP, cortical plate; M,
meninges. Scale bar, 200 mm. (B and D) Con-
focal microscopic analysis of GFP (green)
and GFAP (B) or NeuN (D) (both red) in the
P4 SVZ (B) or CP (D) of animals transfected
with the scrambled oligonucleotide. Arrows
and arrowheads indicate double-labeled
cells and cells that are GFP positive but
marker negative, respectively. Scale bars,
50 mm. (C and E) Quantitation of sections
similar to those in (B) and (D). Transfected
cells within the SVZ (C) or CP (E) of four
scrambled and four gp130 siRNA electropo-
rated animals (four sections per brain) were
counted. *p < 0.05, **p < 0.01 relative to
scrambled oligonucleotide controls (AN-
OVA). Error bars indicate SEM. (F–H) Car-
diotrophin-1 is expressed by developing
cortical neurons. (F) RT-PCRs for CT-1 and
LIF mRNAs in E12, E13, or E17.5 cortex
and cultured cortical neurons (CN). GAPDH
was used as a loading and genomic DNA
contamination control. (G) Western blot for
CT-1 in equal volumes of concentrated CM
from CT-12/2 (KO) and CT-1+/+ (WT) pre-
cursors cultured 4 DIV, or from developing
cortical neurons (CN). Purified murine CT-1
was analyzed directly (10 ng, 5 ng) or after
concentration in control medium ([10ng]).
Asterisks indicate a band enriched in neu-
ron-derived CM, clearly detected in CT-1+/+
CM after a longer exposure (data not shown)
but absent from CT-12/2 CM. (H) Immunos-
taining of E18 coronal cortical sections for
CT-1 (red) and the neuronal protein HuD
(green). Scale bar, 100 mm.cytokine coreceptor, gp130, in embryonic cortical pre-
cursor cells.
CT-1 Is Produced by Newly Born Cortical Neurons
and Is Responsible for the Gliogenic Effects of CM
Our RT-PCR analysis (Figure 2D) demonstrated that de-
veloping cortical neurons express at least three glio-
genic cytokines, CNTF, LIF, and CT-1. Since CNTF is
not expressed in the embryonic brain (Stockli et al.,
1991), and sinceCNTF2/2mice have no alterations in as-
trocyte number in the adult brain (Barres et al., 1996;
Martin et al., 2003), we focused upon CT-1, which is ex-
pressed in the embryonic cortex (Oppenheim et al.,
2001) and LIF, which is expressed in neurons throughout
the adult brain (Lemke et al., 1996). Initially, we charac-
terized expression of CT-1 and LIF in vivo. RT-PCR anal-
ysis of the E12 to E17.5 cortex revealed that CT-1 was
barely detectable at E12 or E13 but was readily detect-
able by E17.5 (Figure 6F), confirming previous analyses(Oppenheim et al., 2001; Sheng et al., 1996). In contrast,
LIF mRNA was undetectable in the embryonic cortex
(Figure 6F). To ask what cells expressed CT-1 in vivo,
we performed immunocytochemistry on the E18 cortex
and demonstrated that CT-1 was enriched in HuD- and
NeuN-positive neurons in the cortical plate but was not
detectably expressed in the VZ/SVZ (Figure 6H; Figure
S3D). The specificity of this immunostaining was dem-
onstrated by preabsorbing the antibody with CT-1 (Fig-
ure S3D). To further confirm that embryonic cortical
neurons synthesize and secrete CT-1, we cultured neu-
rons or cortical precursors from wild-type or CT-12/2
mice (Oppenheim et al., 2001) for 4 days and generated
CM from these cultures for 1 additional day. Western
blots of the concentrated CM demonstrated that a CT-
1 immunoreactive band was detectable in CM generated
from CT-1+/+ but not CT-12/2 precursors and that this
same immunoreactive protein was present at higher lev-
els in CM from cortical neurons (Figure 6G).
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Astrogliogenesis in Culture
(A) Percentage of GFAP- and MAP2-positive cells in precursors cul-
tured 5 days in 4 DIV CM with or without control goat IgG, CT-1 func-
tion-blocking antibody (expt. 1 and expt. 2), or LIF function-blocking
antibody (expt. 2). Alternatively, CM was depleted for LIF by immu-
noprecipitation with a different LIF antibody prior to addition to cells
(expt. 1). ***p < 0.001, ANOVA. Error bars indicate SEM.
(B) Western blots of precursors grown 5 days in control medium, or
in 4 DIV CM plus CT-1 function-blocking antibody or control goat IgG
and probed for GFAP, bIII-tubulin, and total ERKs.
(C and D) Wild-type precursors cultured 4 days with control medium
or with 4 DIV CM from CT-12/2 (KO) or CT-1+/2 (Het) precursors. (C)
Western blots for GFAP, NFM, and total ERKs. (D) Percentage of
cells immunoreactive for GFAP or MAP2 in these cultures. *p <
0.05, KO versus no CM and Het versus KO, ANOVA. Representative
results from one of three experiments are shown in each of (B)–(D).
Error bars indicate SEM.
(E–G) Precursors were isolated from CT-12/2 (KO), CT-1+/2 (Het), or
CT-1+/+ (WT) embryos, cultured for 6 days, and analyzed by Western
blots for GFAP, bIII-tubulin, and total ERKs as a loading control (E) or
immunocytochemically for astrocytic and neuronal markers (F and
G). (F and G) Percentage of cells immunoreactive for GFAP (F and
G), HuD (F), or MAP2 (G) in CT-12/2 versus CT-1+/2 cultures. (F)
and (G) derive from independent experiments. ***p < 0.001, ANOVATo ask whether CT-1 or LIF was responsible for the
gliogenic effect of CM, E13 precursor cell cultures
were incubated with 4 DIV CM in the presence or ab-
sence of function-blocking antibodies to either CT-1
(Chen and von Bartheld, 2004) or LIF (Mi et al., 2001). Im-
munocytochemistry and Western blots for GFAP and
CD44 (Figures 7A and 7B and data not shown) 4 days
later demonstrated that anti-CT-1 almost completely
blocked the gliogenic effects of CM, while anti-LIF had
no effect. In contrast, neither antibody affected the
numbers of MAP2- or bIII-tubulin-positive neurons (Fig-
ure 7A). As further confirmation, we generated 4 DIV CM
from CT-12/2 versus CT-1+/2 cortical precursors and
treated wild-type cultures with these different CM. Im-
munocytochemistry and Western blots 4 days later re-
vealed that the number of astrocytes, but not neurons,
was significantly reduced in cultures treated with CT-
12/2 versus CT-1+/2 CM (Figures 7C and 7D). Thus,
CT-1 is produced by developing cortical neurons and
is a major CM gliogenic factor.
Neuron-Derived CT-1 Is Essential for Normal
Gliogenesis in Culture and In Vivo
These data suggest that neuron-derived CT-1 provides
a feedback mechanism essential for the genesis of as-
trocytes. One prediction of this model is that loss of
CT-1 should lead to a delay and/or reduction in endog-
enous astrocyte formation. To test this prediction, we
cultured cortical precursors from CT-12/2 versus CT-
1+/2 or CT-1+/+ littermates and analyzed them at 6 DIV.
Immunocytochemical and Western blot analyses re-
vealed a dramatic reduction in the numbers of GFAP-
positive astrocytes in these cultures, with no significant
effect on the numbers of neurons (Figures 7E–7G). Con-
firmation of this result was obtained by analyzing wild-
type precursors cultured with function-blocking CT-1
antibody. Immunocytochemistry and Western blots
demonstrated that anti-CT-1 blocked the endogenous
genesis of cells expressing both GFAP and CD44 in
these cultures (Figures 7H and 7I; data not shown) with-
out affecting neurogenesis. Thus, endogenous CT-1 is
essential for endogenous astrogenesis in culture.
We then asked whether CT-1 was also important in
vivo by analyzing the cortex of neonatal CT-12/2 mice,
utilizing both GFAP and CD44 as astrocytic markers.
To confirm that CD44 was expressed in early cortical as-
trocytes in vivo as we had demonstrated in vitro (Fig-
ures S1B and S1C), we performed double-label
immunocytochemistry for CD44 and GFAP. At P1, the
large majority of CD44-positive cells were present in
the VZ/SVZ, and almost all of them were GFAP positive
(Figure 8A). Conversely, many of the GFAP-positive
cells in the SVZ were CD44 positive. We then performed
Western blot analysis for CD44 and GFAP in the P0
or P1 CT-12/2 versus CT-1+/+ cortex. This analysis
revealed reduced levels of both of these astrocyte
(F) and Student’s t test (G). Error bars indicate SEM.
(H and I) Precursors were grown for 6 days in control medium sup-
plemented with either goat IgG (control) or anti-CT-1 function-block-
ing antibody (anti-CT-1). (H) Quantitation of the number of cells
immunoreactive for GFAP or MAP2. ***p < 0.001, Student’s t test.
Representative results from one of three experiments. Error bars in-
dicate SEM. (I) Western blots for GFAP, bIII-tubulin, and total ERKs.
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262Figure 8. Cardiotrophin-1 but Not LIF Is Es-
sential for Appropriate Cortical Astrogenesis
In Vivo
(A) Photomicrographs of a coronal section
through the neonatal cortical SVZ double-la-
beled for CD44 (red) and GFAP (green) and
counterstained with Hoechst 33258 (blue).
The merge shows just the CD44 and GFAP
fluorescence. Scale bar, 50 mm.
(B) Cortices isolated from P0 (left) or P1
(right) CT-12/2 (KO) or CT-1+/+ (WT) mice
and analyzed by Western blots for CD44,
GFAP, NFM, or total ERKs.
(C–F) P3 or P7 CT-1 or P3 LIF2/2 (KO), +/-
(Het), and +/+ (WT) brains were analyzed
immunocytochemically for GFAP. (C) Sche-
matic of the quantified regions of the caudal
cortical SVZ (boxed areas). (D) GFAP fluores-
cence intensity per defined area from sec-
tions similar to those in (E) through SVZ
region 1 as defined in (C). (E and F) GFAP im-
munofluorescence (red) in SVZ regions 1 (E)
and 2 (F) of P3 CT-1+/2 (Het) versus CT-12/2
(KO) mice. SVZ regions were defined by
Hoechst labeling (blue). Arrows highlight re-
gions of reduced GFAP staining in the knock-
outs. Scale bars, 100 (E) or 50 (F) mm. (G)
GFAP-positive cell density in P3 CT-12/2
(KO) or CT-1+/+ (WT) cortical regions 1 and 2
as analyzed by DAB immunocytochemistry.proteins in the absence of CT-1, while no differences
were observed in levels of NFM (Figure 8B). To further
characterize this reduction, we performed GFAP immu-
nocytochemistry on the CT-12/2 cortex at P3 and P7
and quantitated the immunofluorescence signal in a de-
fined region of the dorsal SVZ (region 1; Figures 8C–8F).
This analysis demonstrated a 50%–75% reduction in
GFAP signal throughout the CT-12/2 SVZ at both of
these time points (Figure 8D), in good agreement with
the Western blot data (Figure 8B). In contrast, a similar
analysis of the dorsal SVZ of P3 LIF2/2 animals showed
no reduction in GFAP fluorescence intensity (Figure 8D).
Finally, to confirm that this decrease in astrocytic pro-
teins reflected a decrease in astrocyte numbers, we
quantitated the density of GFAP-positive cells in two
defined regions of the cortical SVZ (Figure 8C) using
DAB immunohistochemistry. This analysis revealed
that the density of GFAP-positive astrocytes in the P3
CT-12/2 cortex was decreased 50%–75% relative to
the CT-1+/+ cortex (Figure 8G). Thus, neuron-derived
CT-1 but not LIF is essential in vivo for appropriate glio-
genesis in the developing cortex.
Discussion
These results support three major conclusions. First,
our culture studies indicate that newly born corticalneurons express gliogenic cytokines that instruct multi-
potent cortical precursors to generate astrocytes,
thereby regulating the temporal onset of gliogenesis.
Second, our in vivo work indicates that early cortical
precursors are competent to produce astrocytes but
fail to do so because they require gliogenic cytokine sig-
naling that only occurs late during embryogenesis.
Third, we demonstrate that the cytokine CT-1 is highly
enriched in embryonic cortical neurons, and this neu-
ron-derived CT-1 is essential for astrogenesis in culture
and in vivo. Together, these findings support a develop-
mental mechanism by which cortical precursors first
generate neurons that produce and secrete the cytokine
CT-1, which then provides a feedback loop to direct the
parent cortical precursors to start making astrocytes.
Such a mechanism provides an unanticipated level of
crosstalk between these different developing cellular
populations and ensures that astrocytes are made
only after sufficient numbers of neurons are generated.
Our in utero electroporation data argue that cortical
precursors are competent to generate astrocytes in re-
sponse to cytokines as early as E13/E14 in vivo and
from E11.5 in vitro. That they do not do so argues that
environmental cytokine levels are limiting, in spite of
the recent finding that two cytokines, neuropoietin and
cardiotrophin-like cytokine, are expressed in embry-
onic mouse neuroepithelia (Uemura et al., 2002;
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Morrow et al. (2001) showed that the postnatal but not
embryonic cortical environment directed embryonic
cortical precursors to generate astrocytes. Our data in-
dicate that this difference in cortical environment is at
least partially due to neuron-derived CT-1. These find-
ings do not, however, exclude the possibility that prior
to E13/E14, cortical precursors undergo an intrinsic
change such as demethylation of STAT binding sites
on astrocyte gene promoters (Takizawa et al., 2001)
that allows them to respond to cytokines. Moreover,
other intrinsic alterations such as EGFR expression
(Burrows et al., 1997) or interactions between the JAK-
STAT pathway and HLH proteins and/or the Notch
pathway (Kamakura et al., 2004; He et al., 2005) may
render cortical precursors more responsive to low cyto-
kine levels. Nonetheless, our data strongly argue that
neuron-derived CT-1 provides a key extrinsic signal
for determining when and how many astrocytes are
generated in the developing cortex.
The idea that cytokines are important for astroglio-
genesis is well supported; CNTF, LIF, and CT-1 all
promote gliogenesis in cultured precursors via a
gp130-JAK-STAT pathway (Bonni et al., 1997; Rajan
and McKay, 1998; Nakashima et al., 1999b; Ochiai
et al., 2001), and while mice lacking CNTF and LIF do
not display deficits in adult astrocyte number (Barres
et al., 1996; Martin et al., 2003) or cortical gliogenesis
(data reported here), respectively, mice lacking gp130
or LIFR have significantly reduced numbers of CNS as-
trocytes (Ware et al., 1995; Koblar et al., 1998; Naka-
shima et al., 1999a). Here, we demonstrate that
neuron-derived CT-1 is a key player in a feedback
mechanism regulating the switch from neurogenesis
to gliogenesis in the cortex. Since a similar develop-
mental switch occurs throughout the developing CNS,
and since deficits in astrocyte number are widespread
in the gp1302/2 and LIFR2/2 mice, then such a neuron-
based feedback mechanism may be important through-
out the embryonic brain and spinal cord. Moreover, if
neurons produce cytokines like CT-1 into adulthood,
then this might explain why precursors transplanted
into the postnatal brain or an injured CNS environment
generate virtually exclusively glial cells (Morrow et al.,
2001; Vroemen et al., 2003).
The deficit in astrocyte formation shown here is very
dramatic in precursor cultures depleted of CT-1, and as-
trocyte numbers are reduced 50%–75% in the neonatal
CT-12/2 cortex. However, while this is a robust de-
crease, it is not as dramatic as that seen in the LIFR2/2
or gp1302/2 mice (Ware et al., 1995; Koblar et al.,
1998; Nakashima et al., 1999a). This difference may be
due to the synthesis of other cytokines by developing
neurons, as we demonstrate here. In this regard, since
in vivo expression of LIF (shown here) and CNTF (Stockli
et al., 1991) commences postnatally, and since adult
LIF2/2 mice have reduced numbers of hippocampal as-
trocytes (Koblar et al., 1998; Bugga et al., 1998), then we
propose that these other cytokines provide compensa-
tory/additional neuron-derived cytokines, particularly
in a CT-12/2 background. Moreover, astrocytes (Lillien
et al., 1988) can produce gliogenic cytokines like
CNTF, suggesting that once the first astrocytes are
made, they may themselves participate in determiningastrocytic density. In this regard, potential compensa-
tory effects are not likely due to upregulation of LIF
or CNTF, since neither mRNA is increased in adult CT-
12/2 mice (Oppenheim et al., 2001). However, previous
work with facial motor neurons (Sendtner et al., 1996)
demonstrated that compensation/collaboration can
nonetheless occur; while LIF2/2 mice showed no motor
neuron degeneration, LIF2/2, CNTF2/2 mice displayed
considerably enhanced neuronal degeneration relative
to mice lacking CNTF alone, even though there was no
upregulation of LIF mRNA in the CNTF2/2 mice.
One surprising result reported here is that cytokines
signal via the gp130-JAK-STAT pathway to inhibit neuro-
genesis. Interestingly, signals that promote cortical neu-
rogenesis such as the MEK-C/EBP pathway (Me´nard
et al., 2002; Barnabe´-Heider and Miller, 2003; A. Paquin,
F.B.-H., R. Kageyama, and F.D.M., unpublished data)
and neurogenic bHLHs (Sun et al., 2001), also inhibit glio-
genesis. Thus, in both the CNS and PNS (Shah et al.,
1994), growth factors in the embryonic neural environ-
ment actively bias precursors toward one fate and
against another.
The idea of developmental timers is well established,
but in most cases the underlying mechanism is thought
to be a cell-intrinsic clock that is tied to the cell cycle (re-
viewed in Raff et al., 2001; Bessho and Kageyama,
2003). Here, we present a different timer mechanism,
by which one class of daughter cells, neurons, secretes
CT-1, thereby altering the environment of the parent
precursors to favor production of a second class of
daughter cells, astrocytes. Thus, these findings not
only provide insights into cortical development, but
also raise the possibility that a similar feedback mecha-
nism may underlie the sequential genesis of cell types in
other developing systems.
Experimental Procedures
Cortical Precursor and FACS-Purified Neuron Cultures
Cortical precursors and postmitotic neurons were cultured as de-
scribed in 40 ng/ml FGF2 (Me´nard et al., 2002; Barnabe´-Heider and
Miller, 2003) from CD1 mice, actin:EYFP transgenic mice (Hadjanto-
nakis et al., 1998), K6 Ta1:nlacZ transgenic mice (Gloster et al., 1999),
or CT-12/2 mice (Oppenheim et al., 2001) at a density of 200,000
cells/ml with, for clonal cultures, 1500 cells/ml of transgenic cells.
For sorted neurons, cortical tissue from aged-matched K6 or control
CD1 embryos were dissociated with papain (Schinelli et al., 1994),
labeled with propidium iodide (20 ng/ml; Sigma) and FDG (Molecular
Probes), sorted using Dako Cytomation MoFlo, and cultured as
above. CM was collected by filtration through 0.22 mm pores and
supplemented with B27, glutamine, and FGF2 for addition to precur-
sor cells at 90% (50% for heat-denatured medium). CNTF, CT-1 (both
Cedarlane Laboratories), and LIF (Sigma) were used at 50 ng/ml.
Inhibitor Treatments and Transfection of Precursor Cultures
AG490 5 mM (Calbiochem) and PD98059 50 mM (BIOMOL Research
Laboratories) in 1% DMSO were added after 3 DIV, and cultures
were analyzed 2 days later. CT-1 or LIF function-blocking antibodies
or control goat IgG was added at the time of plating (5 mg/ml; R&D
Systems). CM was depleted of LIF by incubation overnight at 4ºC
with a rabbit LIF antibody (5 mg/ml, Santa Cruz), addition of 30 ml
of protein A Sepharose beads (Sigma) for 1 hr, and centrifugation.
For transfections, plasmids used were pEGFP (Clonetech), pSi-
lencer (Ambion) with or without a STAT3 siRNA sequence (50-
TCAGGTTGCTGGTCAAATT-30), or the pCAGGS expression vector
with or without a rat CNTF sequence engineered for secretion (the
kind gift of Dr. Miyazaki [Jiang et al., 2003]). Three hours after plat-
ing, precursors were transfected using Fugene6 (Roche), mixing
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2640.33 mg pEGFP, 0.66 mg STAT3 siRNA or CNTF plasmids, 1.5 ml Fu-
gene6, and 100 ml OptiMEM (Invitrogen). Alternatively, precursors
were transfected at 1 DIV with 60 pmol of siRNA oligonucleotides
targeted to gp130 (proprietary mixture of four siRNAs from Dharma-
con) or a nonspecific scrambled sequence (50-AAAGGTTAGCCTA
CATTACAG-30) with 2 mg EGFP using Lipofectamine 2000 (Invi-
trogen). Cos cells and NIH-3T3 cells were transfected using Lipo-
fectamine 2000.
In Utero Electroporation
In utero electroporation was performed as described (Ohtsuka
et al., 1999) with E13.5– E15 CD1 mice by injecting a nuclear GFP ex-
pression plasmid driven from the EF1 promoter (the kind gift of Dr.
R. Kageyama) (5 mg/ml) with 20 pmol siRNA or a 1:3 ratio of
GFP:pCAGGS (5 mg/ml) and 0.05% trypan blue as a tracer. The
square electroporator CUY21 EDIT (TR Tech, Japan) was used to
deliver five 50 ms pulses of 50 V with 950 ms intervals per embryo.
Brains were fixed in 4% PFA at 4ºC overnight, cryoprotected, and
cryosectioned coronally at 16 mm.
Immunocytochemistry and Quantitation
Immunocytochemistry on cells was performed as described (Toma
et al., 2000; Barnabe´-Heider and Miller, 2003). For immunostaining
of tissue sections, sections were postfixed with 4% PFA, blocked,
and permeabilized with 10% BSA and 0.3% Triton-X, and then
with the M.O.M. blocking kit (Vector Laboratories). Sections were in-
cubated with primary antibodies at 4ºC overnight, with secondary
antibodies at room temperature for 1 hr, counterstained with
Hoechst 33258 (1:2000; Sigma-Aldrich) and mounted with GelTol
(Fisher). All antibodies are listed in the Supplemental Data. For
quantitation, six to eight random fields of cultured cells (per treat-
ment per experiment) were captured and processed. For quantita-
tion of GFAP immunohistochemistry from neonatal CT-12/2 and
LIF2/2 mice (Oppenheim et al., 2001; Sendtner et al., 1996), tissue
sections were selected from identical rostrocaudal levels of 2/2,
+/2, and +/+ littermates. Cell counts were made from defined re-
gions on sections processed using DAB. For unbiased GFAP fluo-
rescence measurements, Hoechst-labeled fields were used to
define regions of the SVZ, and fluorescence was automatically cap-
tured from the corresponding GFAP image. Digital image acquisi-
tion and analysis were performed using Northern Eclipse software
(Empix Inc.) with a Sony XC-75CE CCD video camera. For electro-
porated brains, sections were analyzed using a Zeiss Pascal confo-
cal microscope and the manufacturer’s software. Two to three
pictures per coronal section were taken with a 203 objective, and
a total of four sections per animal were analyzed. In all graphs, error
bars indicate standard error of the mean (SEM), and statistics were
performed using one-way ANOVA with the Student-Newman-Keuls
post hoc test or Student’s t test, as appropriate.
Western Blot Analysis and Biochemistry
Cortical precursors and neonatal cortices were lysed, and Western
blots were performed as described (Barnabe´-Heider and Miller,
2003). For acute stimulation experiments, precursors were first
washed for 1 hr. For CT-1 analysis, primary cells were cultured for
4 days and switched to OptiMEM for 24 hr, and the resultant CM
was concentrated using iCON concentrator filters (9 kDa cut-off;
Pierce) and analyzed by SDS-PAGE. Membranes were blocked in
5% skim milk powder, or in 3% BSA for phospho-JAK2, CD44, and
CT-1 antibodies. All antibodies are listed in the Supplemental Data.
RT-PCR Analysis
RNA was extracted using Trizol reagent (Invitrogen) and treated with
DNase (Fermentas) for 30 min at 37ºC. cDNA was synthesized from
300–1000 ng of RNA using murine leukemia virus reverse transcrip-
tase (Fermentas). After reverse transcription, 1 ml of each RT mixture
was subjected to PCR using Taq polymerase (Fermentas) under the
following conditions: 95ºC for 9 min, 40 cycles of 94ºC 20 s, 60ºC
20 s, 72ºC 30 s, and 72ºC 5 min. Primers are listed in the Supplemen-
tal Data.
Supplemental Data
The Supplemental Data include Supplemental Experimental Proce-
dures and three supplemental figures and can be found with thisarticle online at http://www.neuron.org/cgi/content/full/48/2/253/
DC1/.
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